Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020735 220007718 1.68 74.1 Adjuvant (A) 2014-10-18 2015-01-31 Triple / Double Intrathecal Therapy N N 220029749 TRIPLE INTRATHECAL
220020736 220007724 1.78 133.6 Disease modification (D) 2016-01-13 2016-01-13 BOSUTINIB N N 220029760 BOSUTINIB
220020737 220007730 1.85 87.3 Not known (9) 2016-03-22 2016-03-22 BOSUTINIB N null 220029771 BOSUTINIB
220020738 220007745 1.7 83.7 Disease modification (D) 2016-05-26 2016-05-26 AML16 DA 3+8 N N 220029817 AML16 TRIAL
220020741 220007771 1.63 87 Curative (C) 2018-09-06 2018-09-13 FLAG 2 N 220029903 FLAG
220020742 220007776 1.84 109.1 null null 2018-06-18 Cyclophosphamide+Fludara+TBI Allo 2 N 220029943 CYCLOPHOSPHAMIDE + FLUDARABINE
220020743 220007790 1.58 39.8 Curative (C) 2015-06-01 2015-06-01 CYCLOPHOSPHAMIDE + FLUDARABINE 02 N 220029989 CYCLOPHOSPHAMIDE + FLUDARABINE
220020744 220007799 1.68 75 Curative (C) 2016-09-30 2016-10-03 Cyclophosphamide+Fludara+TBI Allo N N 220030038 CYCLOPHOSPHAMIDE + FLUDARABINE
220020745 220007804 null null Palliative (P) 2017-03-17 2017-07-07 Idarubicin+Tretinoin Spanish Crse4 N N 220030047 IDARUBICIN + TRETINOIN
220020746 220007815 1.74 79.9 Curative (C) 2018-04-25 2018-05-15 ATG + Busulfan + Fludarabine N N 220030066 ATG + BUSULFAN + FLUDARABINE
220020747 220017804 1.74 60 Curative (C) 2017-07-27 2017-08-01 Cyclophosphamide TBI Allograft 2 N 220030089 CYCLOPHOSPHAMIDE
220020748 220007824 1.62 null Disease modification (D) null 2016-08-11 BOSUTINIB N null 220030093 BOSUTINIB
220020749 220007829 1.91 97.8 Curative (C) 2013-09-17 2014-04-30 Idarubicin+Tretinoin Spanish Crse4 Y N 220030109 IDARUBICIN + TRETINOIN
220020750 220014310 0 105.5 Curative (C) 2016-05-03 2016-05-03 CYCLOPHOSPHAMIDE N N 220030114 CYCLOPHOSPHAMIDE
220020751 220014314 1.67 null Disease modification (D) 2015-10-14 2015-10-15 ATG + Busulfan + Fludarabine N N 220030142 ATG + BUSULFAN + FLUDARABINE
220020752 220007838 1.51 50.6 Curative (C) 2015-12-01 2015-12-01 CYCLOPHOSPHAMIDE N null 220030144 CYCLOPHOSPHAMIDE
220020753 220007843 1.62 67 Curative (C) 2014-03-10 2014-03-14 AML Int Guide ADE 8+3+5 (2) 02 N 220030145 ADE
220020754 220007846 null 67 Disease modification (D) 2018-12-24 2018-12-26 CYCLOPHOSPHAMIDE null N 220030148 CYCLOPHOSPHAMIDE
220020755 220007853 1.72 67 Curative (C) 2018-10-18 2019-04-18 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220030168 CYCLOPHOSPHAMIDE + FLUDARABINE
220020756 220007857 1.57 79.9 Disease modification (D) 2017-02-28 2017-03-07 ATG + Busulfan + Fludarabine N N 220030182 ATG + BUSULFAN + FLUDARABINE
220020757 220007862 1.8 76 Palliative (P) 2018-10-04 2018-10-15 AML16 DA 3+8 N N 220030188 AML16 TRIAL
220020758 220007874 1.51 65.7 Curative (C) 2017-07-13 2017-07-14 FLAG 02 N 220030225 FLAG
220020759 220007880 1.57 null Palliative (P) 2017-01-01 2017-07-13 BOSUTINIB N N 220030233 BOSUTINIB
220020761 220014336 1.66 75 Curative (C) 2016-03-09 2016-09-22 Idarubicin+Tretinoin Spanish Crse4 N N 220030293 IDARUBICIN + TRETINOIN
220020762 220007906 1.53 54.6 Disease modification (D) 2017-06-06 2017-06-10 BOSUTINIB N N 220030299 BOSUTINIB
220020763 220007916 1.66 null Curative (C) 2016-02-02 2016-02-05 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220030316 CYCLOPHOSPHAMIDE + FLUDARABINE
220020764 220007924 1.56 71.45 Disease modification (D) 2015-09-23 2015-09-30 FLAG N N 220030337 FLAG
220020765 220017824 null null Curative (C) 2013-10-04 2014-02-02 Triple / Double Intrathecal Therapy 02 N 220030339 TRIPLE INTRATHECAL
220020766 220007929 1.75 55 Curative (C) 2013-12-31 2014-01-01 Methotrexate intrathecal N N 220030353 METHOTREXATE INTRATHECAL
220020767 220014353 1.64 60.3 Disease modification (D) 2015-07-23 2015-07-23 Idarubicin+Tretinoin Spanish Crse4 02 N 220030395 IDARUBICIN + TRETINOIN
220020768 220017833 1.69 null Curative (C) 2017-10-05 2017-12-06 RUXOLITINIB N N 220030435 RUXOLITINIB
220020769 220007956 0 0 Curative (C) 2017-07-30 2017-08-02 FLAG 2 N 220030458 FLAG
220020770 220007960 null 56.7 Curative (C) 2015-03-10 2015-04-12 Triple / Double Intrathecal Therapy N N 220030471 TRIPLE INTRATHECAL
220020771 220017839 1.7 null Disease modification (D) 2018-08-13 2018-08-20 Idarubicin+Tretinoin Spanish Crse1 N N 220030475 IDARUBICIN + TRETINOIN
220020772 220017841 1.62 67.6 Curative (C) 2018-03-01 2018-03-01 FLAG 02 null 220030478 FLAG
220020773 220007979 1.86 105 Curative (C) 2014-10-12 2015-02-10 AML16 LD Clofarabine N N 220030495 AML16 TRIAL
220020774 220014377 1.52 53.3 Curative (C) 2014-05-06 2014-05-17 IDARUBICIN + TRETINOIN N N 220030497 IDARUBICIN + TRETINOIN
220020775 220007992 1.77 null Disease modification (D) null 2014-02-11 BOSUTINIB N N 220030524 BOSUTINIB
220020776 220007996 null 10 Curative (C) 2014-02-14 2015-01-29 Triple Intrathecal N null 220030530 TRIPLE INTRATHECAL
220020777 220008000 null null Disease modification (D) 2016-08-22 2016-08-29 ATG + Busulfan + Fludarabine 99 N 220030535 ATG + BUSULFAN + FLUDARABINE
220020778 220008006 1.59 29 Curative (C) 2014-09-14 2016-03-10 BOSUTINIB 2 N 220030541 BOSUTINIB
220020779 220008012 1.67 0 Curative (C) 2015-01-12 2015-03-25 FLAG N N 220030561 FLAG
220020780 220014390 1.79 null Curative (C) 2017-10-23 2017-10-23 AML Int Guide ADE 8+3+5 (2) 2 N 220030565 ADE
220020781 220014398 1.5 75.6 Curative (C) 2016-08-14 2016-08-17 Triple Intrathecal 2 N 220030624 TRIPLE INTRATHECAL
220020782 220014399 null 90 Disease modification (D) 2015-01-29 2015-03-18 ATG + Busulfan + Fludarabine N N 220030630 ATG + BUSULFAN + FLUDARABINE
220020783 220014402 1.84 71.8 Curative (C) 2018-07-20 2018-09-10 ATG + Busulfan + Fludarabine 2 N 220030653 ATG + BUSULFAN + FLUDARABINE
220020784 220008046 1.56 null Curative (C) 2013-08-24 2013-09-01 IDARUBICIN + TRETINOIN null null 220030661 IDARUBICIN + TRETINOIN
220020785 220008050 1.73 66.2 Curative (C) 2016-01-31 2016-01-31 ATG + Busulfan + Fludarabine N N 220030685 ATG + BUSULFAN + FLUDARABINE
220020786 220008052 1.84 20 Disease modification (D) 2013-05-15 2013-05-20 RUXOLITINIB 02 N 220030691 RUXOLITINIB
220020787 220008078 1.65 70 Curative (C) null 2016-01-31 IDARUBICIN + TRETINOIN N N 220030743 IDARUBICIN + TRETINOIN